Chinese Dizal Pharma raises $100m from Lilly Asia, Sequoia, others

Chinese Dizal Pharma raises $100m from Lilly Asia, Sequoia, others

Liya Su

20 August, 2020

Dizal Pharmaceutical (Dizal Pharma)Lilly Asia Ventures (LAV)Sequoia Capital China

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

You may also like

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.